Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.32
CI's Cash to Debt is ranked higher than
57% of the 40 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.63 vs. CI: 0.32 )
CI' s 10-Year Cash to Debt Range
Min: 0.32   Max: No Debt
Current: 0.32

Equity to Asset 0.20
CI's Equity to Asset is ranked higher than
51% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. CI: 0.20 )
CI' s 10-Year Equity to Asset Range
Min: 0.04   Max: 0.2
Current: 0.2

0.04
0.2
Interest Coverage 8.24
CI's Interest Coverage is ranked higher than
67% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.29 vs. CI: 8.24 )
CI' s 10-Year Interest Coverage Range
Min: 8.24   Max: 9999.99
Current: 8.24

8.24
9999.99
F-Score: 7
Z-Score: 1.56
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 9.10
CI's Operating margin (%) is ranked higher than
93% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.96 vs. CI: 9.10 )
CI' s 10-Year Operating margin (%) Range
Min: 1.32   Max: 13.07
Current: 9.1

1.32
13.07
Net-margin (%) 5.85
CI's Net-margin (%) is ranked higher than
95% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.10 vs. CI: 5.85 )
CI' s 10-Year Net-margin (%) Range
Min: -2.31   Max: 9.74
Current: 5.85

-2.31
9.74
ROE (%) 18.80
CI's ROE (%) is ranked higher than
93% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.02 vs. CI: 18.80 )
CI' s 10-Year ROE (%) Range
Min: -9.89   Max: 30.77
Current: 18.8

-9.89
30.77
ROA (%) 3.63
CI's ROA (%) is ranked higher than
81% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.62 vs. CI: 3.63 )
CI' s 10-Year ROA (%) Range
Min: -0.49   Max: 3.11
Current: 3.63

-0.49
3.11
ROC (Joel Greenblatt) (%) 211.23
CI's ROC (Joel Greenblatt) (%) is ranked higher than
81% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 146.02 vs. CI: 211.23 )
CI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 53.46   Max: 272.6
Current: 211.23

53.46
272.6
Revenue Growth (3Y)(%) 13.70
CI's Revenue Growth (3Y)(%) is ranked higher than
73% of the 41 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.10 vs. CI: 13.70 )
CI' s 10-Year Revenue Growth (3Y)(%) Range
Min: -5.5   Max: 19
Current: 13.7

-5.5
19
EBITDA Growth (3Y)(%) 8.60
CI's EBITDA Growth (3Y)(%) is ranked higher than
75% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.90 vs. CI: 8.60 )
CI' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 104.3
Current: 8.6

0
104.3
EPS Growth (3Y)(%) 3.40
CI's EPS Growth (3Y)(%) is ranked higher than
68% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. CI: 3.40 )
CI' s 10-Year EPS Growth (3Y)(%) Range
Min: -32   Max: 79.5
Current: 3.4

-32
79.5
» CI's 10-Y Financials

Financials


Revenue & Net Income
Equity & Asset
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

CI Guru Trades in Q4 2013

Jim Simons 147,100 sh (New)
Caxton Associates 100,000 sh (New)
Lee Ainslie 917,549 sh (New)
David Dreman 2,883 sh (+101.75%)
Pioneer Investments 142,400 sh (+83.98%)
Paul Tudor Jones 10,692 sh (+72.45%)
Jeremy Grantham 154,352 sh (+33.93%)
Richard Pzena 4,145,441 sh (+26.46%)
James Barrow 2,638,491 sh (+0.22%)
Ronald Muhlenkamp 60 sh (unchged)
Bill Frels 4,890 sh (unchged)
John Keeley 8,150 sh (unchged)
Ray Dalio Sold Out
Ken Heebner Sold Out
Larry Robbins 2,694,510 sh (-3.06%)
Vanguard Health Care Fund 6,064,200 sh (-3.25%)
Dodge & Cox 5,297,220 sh (-5.91%)
David Einhorn 4,211,230 sh (-9.33%)
Steven Cohen 4,204 sh (-95.87%)
» More
Q1 2014

CI Guru Trades in Q1 2014

Mario Gabelli 10,050 sh (New)
Ray Dalio 62,981 sh (New)
Steven Cohen 381,772 sh (+8981.16%)
Paul Tudor Jones 20,109 sh (+88.08%)
David Dreman 4,371 sh (+51.61%)
Richard Pzena 4,823,204 sh (+16.35%)
Vanguard Health Care Fund 6,702,300 sh (+10.52%)
James Barrow 2,796,688 sh (+6%)
Dodge & Cox 5,371,387 sh (+1.4%)
David Einhorn 4,211,230 sh (unchged)
John Keeley 8,150 sh (unchged)
Bill Frels 4,890 sh (unchged)
Caxton Associates Sold Out
Lee Ainslie Sold Out
Jim Simons Sold Out
Larry Robbins 2,060,010 sh (-23.55%)
Pioneer Investments 77,400 sh (-45.65%)
Jeremy Grantham 80,000 sh (-48.17%)
» More
Q2 2014

CI Guru Trades in Q2 2014

Joel Greenblatt 23,082 sh (New)
Jim Simons 14,100 sh (New)
David Dreman 5,425 sh (+24.11%)
Dodge & Cox 6,049,387 sh (+12.62%)
Richard Pzena 5,281,715 sh (+9.51%)
Larry Robbins 2,226,626 sh (+8.09%)
James Barrow 2,884,758 sh (+3.15%)
Mario Gabelli 10,050 sh (unchged)
Pioneer Investments 77,400 sh (unchged)
John Keeley 8,150 sh (unchged)
Bill Frels 4,500 sh (-7.98%)
Vanguard Health Care Fund 6,163,900 sh (-8.03%)
David Einhorn 3,096,230 sh (-26.48%)
Ray Dalio 27,081 sh (-57%)
Paul Tudor Jones 8,000 sh (-60.22%)
Jeremy Grantham 5,000 sh (-93.75%)
» More
Q3 2014

CI Guru Trades in Q3 2014

Paul Tudor Jones 16,949 sh (+111.86%)
Dodge & Cox 10,321,737 sh (+70.62%)
Ray Dalio 31,781 sh (+17.36%)
Joel Greenblatt 25,743 sh (+11.53%)
Richard Pzena 5,584,763 sh (+5.74%)
James Barrow 2,927,567 sh (+1.48%)
David Dreman 5,442 sh (+0.31%)
Bill Frels 4,500 sh (unchged)
Pioneer Investments 77,400 sh (unchged)
John Keeley 8,150 sh (unchged)
Mario Gabelli 10,050 sh (unchged)
Vanguard Health Care Fund 6,163,900 sh (unchged)
Ronald Muhlenkamp 60 sh (unchged)
Larry Robbins 2,226,626 sh (unchged)
Jim Simons Sold Out
David Einhorn 2,073,800 sh (-33.02%)
Jeremy Grantham 2,700 sh (-46%)
» More
» Details

Insider Trades

Latest Guru Trades with CI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
David Einhorn 2014-09-30 Reduce -33.02%1.32%$88.75 - $96.87 $ 10411%2073800
Dodge & Cox 2014-09-30 Add 70.62%0.37%$88.75 - $96.87 $ 10411%10321737
Richard Pzena 2014-09-30 Add 5.74%0.15%$88.75 - $96.87 $ 10411%5584763
David Einhorn 2014-06-30 Reduce -26.48%1.4%$75.64 - $92.11 $ 10421%3096230
Richard Pzena 2014-06-30 Add 9.51%0.23%$75.64 - $92.11 $ 10421%5281715
Vanguard Health Care Fund 2014-06-30 Reduce -8.03%0.13%$75.64 - $92.11 $ 10421%6163900
Joel Greenblatt 2014-06-30 New Buy0.03%$75.64 - $92.11 $ 10421%23082
Ray Dalio 2014-06-30 Reduce -57%0.02%$75.64 - $92.11 $ 10421%27081
David Dreman 2014-06-30 Add 24.11%0.01%$75.64 - $92.11 $ 10421%5425
Lee Ainslie 2014-03-31 Sold Out 1%$75.94 - $90.13 $ 10426%0
Richard Pzena 2014-03-31 Add 16.35%0.32%$75.94 - $90.13 $ 10426%4823204
Vanguard Health Care Fund 2014-03-31 Add 10.52%0.15%$75.94 - $90.13 $ 10426%6702300
Ray Dalio 2014-03-31 New Buy0.04%$75.94 - $90.13 $ 10426%62981
David Dreman 2014-03-31 Add 51.61%0.01%$75.94 - $90.13 $ 10426%4371
Mario Gabelli 2014-03-31 New Buy$75.94 - $90.13 $ 10426%10050
Lee Ainslie 2013-12-31 New Buy1%$73.17 - $88.18 $ 10427%917549
David Einhorn 2013-12-31 Reduce -9.33%0.59%$73.17 - $88.18 $ 10427%4211230
Richard Pzena 2013-12-31 Add 26.46%0.44%$73.17 - $88.18 $ 10427%4145441
Ken Heebner 2013-12-31 Sold Out 0.24%$73.17 - $88.18 $ 10427%0
Ray Dalio 2013-12-31 Sold Out 0.04%$73.17 - $88.18 $ 10427%0
David Dreman 2013-12-31 Add 101.75%0.01%$73.17 - $88.18 $ 10427%2883
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 14.20
CI's P/E(ttm) is ranked higher than
96% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 27.40 vs. CI: 14.20 )
CI' s 10-Year P/E(ttm) Range
Min: 3.24   Max: 21.45
Current: 14.2

3.24
21.45
P/B 2.45
CI's P/B is ranked higher than
71% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.46 vs. CI: 2.45 )
CI' s 10-Year P/B Range
Min: 0.52   Max: 3.96
Current: 2.45

0.52
3.96
P/S 0.83
CI's P/S is ranked higher than
65% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.58 vs. CI: 0.83 )
CI' s 10-Year P/S Range
Min: 0.13   Max: 1.05
Current: 0.83

0.13
1.05
PFCF 17.81
CI's PFCF is ranked higher than
76% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.30 vs. CI: 17.81 )
CI' s 10-Year PFCF Range
Min: 1.8   Max: 149.61
Current: 17.81

1.8
149.61
EV-to-EBIT 9.84
CI's EV-to-EBIT is ranked higher than
88% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.39 vs. CI: 9.84 )
CI' s 10-Year EV-to-EBIT Range
Min: 3.3   Max: 17.6
Current: 9.84

3.3
17.6
PEG 1.79
CI's PEG is ranked higher than
88% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.06 vs. CI: 1.79 )
CI' s 10-Year PEG Range
Min: 0.3   Max: 5.06
Current: 1.79

0.3
5.06
Shiller P/E 20.08
CI's Shiller P/E is ranked higher than
88% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 38.96 vs. CI: 20.08 )
CI' s 10-Year Shiller P/E Range
Min: 2.65   Max: 22.68
Current: 20.08

2.65
22.68

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.04
CI's Dividend Yield is ranked lower than
90% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.27 vs. CI: 0.04 )
CI' s 10-Year Dividend Yield Range
Min: 0.04   Max: 2.39
Current: 0.04

0.04
2.39
Dividend Payout 0.01
CI's Dividend Payout is ranked higher than
98% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. CI: 0.01 )
CI' s 10-Year Dividend Payout Range
Min: 0   Max: 0.69
Current: 0.01

0
0.69
Yield on cost (5-Year) 0.10
CI's Yield on cost (5-Year) is ranked lower than
96% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.78 vs. CI: 0.10 )
CI' s 10-Year Yield on cost (5-Year) Range
Min: 0.04   Max: 2.49
Current: 0.1

0.04
2.49
Share Buyback Rate -1.40
CI's Share Buyback Rate is ranked higher than
74% of the 38 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.30 vs. CI: -1.40 )
CI' s 10-Year Share Buyback Rate Range
Min: 11.9   Max: -1.7
Current: -1.4

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 5.30
CI's Price/Tangible Book is ranked higher than
84% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. CI: 5.30 )
CI' s 10-Year Price/Tangible Book Range
Min: 0.98   Max: 27.98
Current: 5.3

0.98
27.98
Price/DCF (Projected) 1.22
CI's Price/DCF (Projected) is ranked higher than
78% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.25 vs. CI: 1.22 )
CI' s 10-Year Price/DCF (Projected) Range
Min: 0.28   Max: 4.9
Current: 1.22

0.28
4.9
Price/Median PS Value 1.36
CI's Price/Median PS Value is ranked higher than
59% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. CI: 1.36 )
CI' s 10-Year Price/Median PS Value Range
Min: 0.4   Max: 1.77
Current: 1.36

0.4
1.77
Price/Peter Lynch Fair Value 1.23
CI's Price/Peter Lynch Fair Value is ranked higher than
94% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. CI: 1.23 )
CI' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.35   Max: 2.96
Current: 1.23

0.35
2.96
Price/Graham Number 1.80
CI's Price/Graham Number is ranked higher than
98% of the 49 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. CI: 1.80 )
CI' s 10-Year Price/Graham Number Range
Min: 0.77   Max: 3.81
Current: 1.8

0.77
3.81
Earnings Yield (Greenblatt) 10.20
CI's Earnings Yield (Greenblatt) is ranked higher than
86% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.40 vs. CI: 10.20 )
CI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 5.7   Max: 29.9
Current: 10.2

5.7
29.9
Forward Rate of Return (Yacktman) 15.85
CI's Forward Rate of Return (Yacktman) is ranked higher than
74% of the 35 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.59 vs. CI: 15.85 )
CI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -3.3   Max: 46.7
Current: 15.85

-3.3
46.7

Business Description

Industry: Health Care Plans » Health Care Plans
Compare:UNH, ESRX, WLP, HUM, AET » details
Traded in other countries:CGN.Germany,
Cigna Corp was incorporated in the State of Delaware in 1981. It is a health services organization with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services. In the U.S., the majority of these products and services are offered through employers and other groups and, in selected international markets. It offers supplemental health, life and accident insurance products and international health care coverage and services to businesses, governmental and non-governmental organizations and individuals. The Company's segments are Global Health Care, Group Disability and Life, Global Supplemental Benefits, Run-off Reinsurance and Other Operations including Corporate-owned Life Insurance. The Global Health Care aggregates two operating segments namely Commercial that includes the international health care business and Government. The Company's Global Health Care segment offers insured and self-funded medical, dental, behavioral health, vision, and prescription drug benefit plans, health advocacy programs and other products and services that might be integrated to provide individuals with complete health care benefit programs. The Company's Group Disability and Life segment provides the insurance products and their related services such as group life insurance, long-term and short-term disability insurance, workers' compensation and disability case management, and accident and specialty insurance. The Global Supplemental Benefits segment is comprised of the international supplemental health, life and accident businesses as well as the Medicare supplement business. This segment offers supplemental health, life and accident insurance products in the U.S. and selected international markets. With local licenses and partnerships in approximately 20 countries and jurisdictions, it is able to offer products and services to local citizens and in other international markets. These products and services are provided by subsidiaries of the Company, including foreign operating entities. The products and services related to these operations were offered by subsidiaries of Cigna Corporation. Other Operations of the Company consists of: non-leveraged and leveraged corporate-owned life insurance; deferred gains recognized from the sale of the individual life insurance and annuity business and the sale of the retirement benefits business and run-off settlement annuity business. The Company's International's life, accident and supplemental health insurance products are sold mainly through direct marketing channels, such as outbound telemarketing, in-branch bancassurance and direct response television. In the HealthCare business, it competes with: insurance companies that provide group health and life insurance products, Blue Cross and Blue Shield organizations; stand-alone HMOs and PPOs; HMOs affiliated with insurance companies and hospitals and national managed pharmacy, beh
» More Articles for CI

Headlines

Articles On GuruFocus.com
UNH: A Strong Candidate for Income and Capital Appreciation Dec 12 2014 
UnitedHealth Releases Optimistic Outlook with Oppenheimer Reiterating an Outperform Rating Dec 04 2014 
Weekly 52-Week Highs Highlight: WYN, WMT, PLD, CI Nov 29 2014 
Cigna and Liazon Join Together to Offer Suite of Products on Liazon's Leading Private Exchange Platf Oct 15 2014 
Add Humana for a Healthier Portfolio Oct 10 2014 
Despite Regulation, Transparency and Competition, Aetna Looks Competitive in the Industry Aug 29 2014 
Weekly CEO Sells Highlight: AmerisourceBergen, Huntsman, Johnson Controls, Cigna, and Foster Wheeler Jun 15 2014 
Greenlight Capital and David Einhorn's Top Five of the First Quarter May 20 2014 
Maintain a Healthy Portfolio with Aetna Mar 24 2014 
Aetna - Why You Shouldn’t Stop Caring About This Health Care Stock Despite ObamaCare Dec 16 2013 


Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK